3 hours Viking Therapeutics Gives Investors Another Reason to Remain Bullish on Its FutureThe Motley Fool
Viking recently announced the results of an early-stage clinical trial for VK0214.
XViking recently announced the results of an early-stage clinical trial for VK0214.
X